View in EDS

CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.

Saved in:
Bibliographic Details
Title: CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Authors: Samain R; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Maiques O; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Monger J; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Lam H; School of Cancer and Pharmaceutical Sciences, Kings College London, London SE1 1UL, UK.; GSK, R&D Portfolio, Strategy and Business Insights, GSK House, 980 Great West Road, Brentford, TW8 9GS, UK., Candido J; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.; Oncology R&D, AstraZeneca, Cambridge CB21 6GH, UK., George S; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Ferrari N; Tumour Microenvironment Team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.; Translational Science and Experimental Medicine, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., KohIhammer L; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Lunetto S; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, UK., Varela A; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Orgaz JL; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.; Instituto de Investigaciones Biomédicas Sols-Morreale CSIC-UAM, 28029 Madrid, Spain., Vilardell F; Department of Pathology, University Hospital Arnau de Vilanova, University of Lleida, Lleida, Spain., Olsina JJ; Department of Surgery, University Hospital Arnau de Vilanova, University of Lleida, Lleida, Spain., Matias-Guiu X; Department of Pathology, University Hospital Arnau de Vilanova, University of Lleida, Lleida, Spain.; IRBLLEIDA, IDIBELL, University Hospita of Bellvitge, CIBERONC, Lleida, Spain., Sarker D; School of Cancer and Pharmaceutical Sciences, Kings College London, London SE1 1UL, UK., Biddle A; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, UK., Balkwill FR; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Eyles J; Oncology R&D, AstraZeneca, Cambridge CB21 6GH, UK., Wilkinson RW; Oncology R&D, AstraZeneca, Cambridge CB21 6GH, UK., Kocher HM; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK., Calvo F; Tumour Microenvironment Team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.; Instituto de Biomedicina y Biotecnologia de Cantabria, c/ Albert Einstein 22, E39011 Santander, Spain., Wells CM; School of Cancer and Pharmaceutical Sciences, Kings College London, London SE1 1UL, UK., Sanz-Moreno V; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Source: Science advances [Sci Adv] 2023 Oct 20; Vol. 9 (42), pp. eadi0244. Date of Electronic Publication: 2023 Oct 18.
Publication Type: Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37851808
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Samain+R%22">Samain R</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.<br /><searchLink fieldCode="AU" term="%22Maiques+O%22">Maiques O</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.<br /><searchLink fieldCode="AU" term="%22Monger+J%22">Monger J</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.<br /><searchLink fieldCode="AU" term="%22Lam+H%22">Lam H</searchLink>; School of Cancer and Pharmaceutical Sciences, Kings College London, London SE1 1UL, UK.; GSK, R&D Portfolio, Strategy and Business Insights, GSK House, 980 Great West Road, Brentford, TW8 9GS, UK.<br /><searchLink fieldCode="AU" term="%22Candido+J%22">Candido J</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.; Oncology R&D, AstraZeneca, Cambridge CB21 6GH, UK.<br /><searchLink fieldCode="AU" term="%22George+S%22">George S</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.<br /><searchLink fieldCode="AU" term="%22Ferrari+N%22">Ferrari N</searchLink>; Tumour Microenvironment Team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.; Translational Science and Experimental Medicine, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22KohIhammer+L%22">KohIhammer L</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.<br /><searchLink fieldCode="AU" term="%22Lunetto+S%22">Lunetto S</searchLink>; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, UK.<br /><searchLink fieldCode="AU" term="%22Varela+A%22">Varela A</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.<br /><searchLink fieldCode="AU" term="%22Orgaz+JL%22">Orgaz JL</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.; Instituto de Investigaciones Biomédicas Sols-Morreale CSIC-UAM, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Vilardell+F%22">Vilardell F</searchLink>; Department of Pathology, University Hospital Arnau de Vilanova, University of Lleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Olsina+JJ%22">Olsina JJ</searchLink>; Department of Surgery, University Hospital Arnau de Vilanova, University of Lleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Matias-Guiu+X%22">Matias-Guiu X</searchLink>; Department of Pathology, University Hospital Arnau de Vilanova, University of Lleida, Lleida, Spain.; IRBLLEIDA, IDIBELL, University Hospita of Bellvitge, CIBERONC, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Sarker+D%22">Sarker D</searchLink>; School of Cancer and Pharmaceutical Sciences, Kings College London, London SE1 1UL, UK.<br /><searchLink fieldCode="AU" term="%22Biddle+A%22">Biddle A</searchLink>; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London E1 2AT, UK.<br /><searchLink fieldCode="AU" term="%22Balkwill+FR%22">Balkwill FR</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.<br /><searchLink fieldCode="AU" term="%22Eyles+J%22">Eyles J</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB21 6GH, UK.<br /><searchLink fieldCode="AU" term="%22Wilkinson+RW%22">Wilkinson RW</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB21 6GH, UK.<br /><searchLink fieldCode="AU" term="%22Kocher+HM%22">Kocher HM</searchLink>; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Calvo+F%22">Calvo F</searchLink>; Tumour Microenvironment Team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.; Instituto de Biomedicina y Biotecnologia de Cantabria, c/ Albert Einstein 22, E39011 Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Wells+CM%22">Wells CM</searchLink>; School of Cancer and Pharmaceutical Sciences, Kings College London, London SE1 1UL, UK.<br /><searchLink fieldCode="AU" term="%22Sanz-Moreno+V%22">Sanz-Moreno V</searchLink>; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101653440%22">Science advances</searchLink> [Sci Adv] 2023 Oct 20; Vol. 9 (42), pp. eadi0244. <i>Date of Electronic Publication: </i>2023 Oct 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101653440 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2375-2548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223752548%22">23752548 </searchLink><i>NLM ISO Abbreviation: </i>Sci Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37851808
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/sciadv.adi0244
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: eadi0244
    Titles:
      – TitleFull: CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Samain R
      – PersonEntity:
          Name:
            NameFull: Maiques O
      – PersonEntity:
          Name:
            NameFull: Monger J
      – PersonEntity:
          Name:
            NameFull: Lam H
      – PersonEntity:
          Name:
            NameFull: Candido J
      – PersonEntity:
          Name:
            NameFull: George S
      – PersonEntity:
          Name:
            NameFull: Ferrari N
      – PersonEntity:
          Name:
            NameFull: KohIhammer L
      – PersonEntity:
          Name:
            NameFull: Lunetto S
      – PersonEntity:
          Name:
            NameFull: Varela A
      – PersonEntity:
          Name:
            NameFull: Orgaz JL
      – PersonEntity:
          Name:
            NameFull: Vilardell F
      – PersonEntity:
          Name:
            NameFull: Olsina JJ
      – PersonEntity:
          Name:
            NameFull: Matias-Guiu X
      – PersonEntity:
          Name:
            NameFull: Sarker D
      – PersonEntity:
          Name:
            NameFull: Biddle A
      – PersonEntity:
          Name:
            NameFull: Balkwill FR
      – PersonEntity:
          Name:
            NameFull: Eyles J
      – PersonEntity:
          Name:
            NameFull: Wilkinson RW
      – PersonEntity:
          Name:
            NameFull: Kocher HM
      – PersonEntity:
          Name:
            NameFull: Calvo F
      – PersonEntity:
          Name:
            NameFull: Wells CM
      – PersonEntity:
          Name:
            NameFull: Sanz-Moreno V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 10
              Text: 2023 Oct 20
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2375-2548
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 42
          Titles:
            – TitleFull: Science advances
              Type: main
ResultId 1